Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Natural product derived phytochemicals in managing acute lung injury by multiple mechanisms
Yu-Qiong He, Cancan Zhou, Luyao Yu, et al.
Pharmacological Research (2020) Vol. 163, pp. 105224-105224
Open Access | Times Cited: 285

Showing 26-50 of 285 citing articles:

Exploring ncRNA-mediated pathways in sepsis-induced pyroptosis
Asif Ahmad Bhat, Yassine Riadi, Muhammad Afzal, et al.
Pathology - Research and Practice (2024) Vol. 256, pp. 155224-155224
Closed Access | Times Cited: 6
Anti-inflammatory properties of polysaccharides from edible fungi on health-promotion: a review
Zhenhua Yin, Juanjuan Zhang, Jingjing Qin, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 6
Efficacy and Safety of Traditional Chinese Medicine in Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis
Heping Wang, Bowen Xu, Ying Zhang, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 40
Baicalein suppresses lipopolysaccharide-induced acute lung injury by regulating Drp1-dependent mitochondrial fission of macrophages
Cheng Jiang, Jiechun Zhang, Huiwen Xie, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 145, pp. 112408-112408
Open Access | Times Cited: 33
A Journey into the Clinical Relevance of Heme Oxygenase 1 for Human Inflammatory Disease and Viral Clearance: Why Does It Matter on the COVID-19 Scene?
Ayelén Toro, María Sol Ruiz, Sofía Lage-Vickers, et al.
Antioxidants (2022) Vol. 11, Iss. 2, pp. 276-276
Open Access | Times Cited: 23
Inhibition of Drp1-dependent mitochondrial fission by natural compounds as a therapeutic strategy for organ injuries
Sohrab Rahmani, Ali Roohbakhsh, Gholamreza Karimi
Pharmacological Research (2023) Vol. 188, pp. 106672-106672
Open Access | Times Cited: 15
Esculin alleviates LPS-induced acute lung injury via inhibiting neutrophil recruitment and migration
Jiangwei Ni, Ge Li, Ningfeng Dai, et al.
International Immunopharmacology (2023) Vol. 119, pp. 110177-110177
Open Access | Times Cited: 15
The protective effects of baicalin for respiratory diseases: an update and future perspectives
Siyu Song, Lu Ding, Guangwen Liu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 14
Chlorogenic acid reduces inflammation by inhibiting the elevated expression of KAT2A to ameliorate lipopolysaccharide‐induced acute lung injury
Bin Lv, Jinhe Guo, Yaodong Du, et al.
British Journal of Pharmacology (2023) Vol. 180, Iss. 16, pp. 2156-2171
Closed Access | Times Cited: 13
Shiwei Qingwen decoction regulates TLR4/NF-κB signaling pathway and NLRP3 inflammasome to reduce inflammatory response in lipopolysaccharide-induced acute lung injury
Qian Zhang, Cheng‐Xiong Yang, Shangzhi Ma, et al.
Journal of Ethnopharmacology (2023) Vol. 313, pp. 116615-116615
Closed Access | Times Cited: 13
Rhein-attenuates LPS-induced acute lung injury via targeting NFATc1/Trem2 axis
Xiang Li, Chuan Xiao, Jia Yuan, et al.
Inflammation Research (2023) Vol. 72, Iss. 6, pp. 1237-1255
Open Access | Times Cited: 13
Urolithin A exerts a protective effect on lipopolysaccharide-induced acute lung injury by regulating HMGB1-mediated MAPK and NF-κB signaling pathways
Pengfei Jiao, Yingrui Wang, Gaofei Ren, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 8, pp. 5765-5777
Closed Access | Times Cited: 5
Sea Cucumber and Blueberry Extracts Suppress Inflammation and Reduce Acute Lung Injury through the Regulation of NF-κB/MAPK/JNK Signaling Pathway in Lipopolysaccharide-Treated C57BL/6 Mice
Oladapo F. Fagbohun, Wasitha P. D. W. Thilakarathna, Juan Zhou, et al.
Molecules (2024) Vol. 29, Iss. 7, pp. 1511-1511
Open Access | Times Cited: 5
Network pharmacology and phytochemical composition combined with validation in vivo and in vitro reveal the mechanism of platycodonis radix ameliorating PM2.5-induced acute lung injury
Xianlei Han, Yue Zhang, Fan Zhang, et al.
Journal of Ethnopharmacology (2024) Vol. 337, pp. 118829-118829
Closed Access | Times Cited: 5
Tanreqing Inhibits LPS-Induced Acute Lung Injury In Vivo and In Vitro Through Downregulating STING Signaling Pathway
Yu-Qiong He, Cancan Zhou, Jiuling Deng, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 32
Multifaceted Roles of Chemokine C-X-C Motif Ligand 7 in Inflammatory Diseases and Cancer
Qianmiao Wu, Huaijun Tu, Jian Li
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 21
Supramolecular erythrocytes-hitchhiking drug delivery system for specific therapy of acute pneumonia
Junyan Li, Yuan‐Fu Ding, Qian Cheng, et al.
Journal of Controlled Release (2022) Vol. 350, pp. 777-786
Closed Access | Times Cited: 21
Caveolin-1 identified as a key mediator of acute lung injury using bioinformatics and functional research
Lihua Qu, Yi Li, Chao Chen, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 8
Open Access | Times Cited: 20
Eupalinolide B attenuates lipopolysaccharide-induced acute lung injury through inhibition of NF-κB and MAPKs signaling by targeting TAK1 protein
Luyao Yang, Hongqing Chen, Qiongying Hu, et al.
International Immunopharmacology (2022) Vol. 111, pp. 109148-109148
Closed Access | Times Cited: 19
Discovery of 4-oxo-N-phenyl-1,4-dihydroquinoline-3-carboxamide derivatives as novel anti-inflammatory agents for the treatment of acute lung injury and sepsis
Jun Yang, Minxiu Wang, Yulan Xu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 249, pp. 115144-115144
Closed Access | Times Cited: 12
Preparation of inhalable quercetin-β-cyclodextrin inclusion complexes using the supercritical antisolvent process for the prevention of smoke inhalation-induced acute lung injury
Wanmei Wang, Yan Liu, Hui Zhang, et al.
Journal of CO2 Utilization (2023) Vol. 69, pp. 102414-102414
Open Access | Times Cited: 12
Pneumolysin as a target for new therapies against pneumococcal infections: A systematic review
Marı́a Dolores Cima-Cabal, Felipe Molina, José Ignacio López Sánchez, et al.
PLoS ONE (2023) Vol. 18, Iss. 3, pp. e0282970-e0282970
Open Access | Times Cited: 12
Polyphosphazene nanodrugs for targeting delivery and inflammation responsive release of curcumin to treat acute lung injury by effectively inhibiting cytokine storms
Xiaochen Su, Xunan Jing, Wan-Ting Jiang, et al.
Colloids and Surfaces B Biointerfaces (2023) Vol. 229, pp. 113446-113446
Closed Access | Times Cited: 12
Quercetin Derivatives as Potential Therapeutic Agents: An Updated Perspective on the Treatment of Nicotine-Induced Non-Small Cell Lung Cancer
Naser A. Alsharairi
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15208-15208
Open Access | Times Cited: 11
Tetrastigma hemsleyanum polysaccharide ameliorates cytokine storm syndrome via the IFN-γ-JAK2/STAT pathway
Siyu Fu, Xiaodan Bao, Zian Mao, et al.
International Journal of Biological Macromolecules (2024) Vol. 275, pp. 133427-133427
Closed Access | Times Cited: 4

Scroll to top